Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: Implications in neuronal plasticity and Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 1086, Issue , 2006, Pages 54-65

  Bailey, Jason A ^a   Lahiri, Debomoy K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Exocytosis; Neuronal culture; Neuronal differentiation; Neuronal plasticity; Neurotransmission; Synaptic vesicle; Synaptosomal protein

Indexed keywords

SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; AMYLOID PRECURSOR PROTEIN; SNAP25 PROTEIN, RAT;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL TISSUE; BRAIN CELL; CELL ISOLATION; CELL STRUCTURE; CONFERENCE PAPER; CYTOSKELETON; EMBRYO; EXOCYTOSIS; FETUS; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN FUNCTION; RAT; ANIMAL; ARTICLE; BRAIN CORTEX; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PREGNANCY;

RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CEREBRAL CORTEX; FEMALE; FETUS; NEURONAL PLASTICITY; NEURONS; PREGNANCY; RATS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 34447526608     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1377.001     Document Type: Conference Paper

References (27)

1. SELKOE, D.J. 2005. Defining molecular targets to prevent Alzheimer disease. Arch. Neurol. 62: 192-195.
2. LAHIRI, D.K., M.R. FARLOW, K. SAMBAMURTI, et al. 2003. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 4: 97-112.
3. CAIRNS, N.J., V.M. LEE & J.Q. TROJANOWSKI. 2004. The cytoskeleton in neurodegenerative diseases. J. Pathol. 204: 438-449.
4. GIACOBINI, E. 2003. Cholinergic function and Alzheimer's disease. Int. J. Geriatr. Psychiatry 18: S1-S5.
5. SAMBAMURTI, K., N.H. GREIG & D.K. LAHIRI. 2002. Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease. Neuromolec. Med. 1: 1-31.
6. SUDHOF, T.C. & R. JAHN. 1991. Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron. 6: 665-677.
7. SORENSEN, J.B. 2005. SNARE complexes prepare for membrane fusion. Trends Neurosci. 28: 453-455.
8. DEKOSKY, S.T., & S.W. SCHEFF. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27: 457-464.
9. TERRY, R.D., E. MASLIAH, D.P. SALMON, et al. 1991. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30: 572-580.
10. MUKAETOVA-LADINSKA, E.B., F. GARCIA- SIERA, J. HURT, et al. 2000. Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. Am. J. Pathol. 157: 623-636.
11. COUNTS, S.E., M. NADEEM, S.P. LAD, et al. 2006. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J. Neuropathol. Exp. Neurol. 65: 592-601.
12. JACOBSEN, J.S., C.C. WU, J.M. REDWINE, et al. 2006. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103: 5161-5166.
13. REDDY, P.H., G. MANI, B.S. PARK, et al. 2005. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J. Alzheimer's Dis. 7: 103-117.
14. GREBER, S., G. LUBEC, N. CAIRNS, et al. 1999. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis 20: 928-934.
15. TAMAGNO, E., P. BARDINI, M. GUGLIELMOTTO, et al. 2006. The various aggregation states of beta-amyloid 1-42 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression. Free Radic. Biol. Med. 41: 202-212.
16. HSIAO, K., P. CHAPMAN, S. NILSEN, et al. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
17. REES, T.M., A. BERSON, E.H. SKLAN, L., et al. 2005. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr. Alzheimer Res. 2: 291-300.
18. CIRRITO, J.R., K.A. YAMADA, M.B. FINN, et al. 2005. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48: 913-922.
19. BREWER, G.J., J.R. TORRICELLI, E.K. EVEGE, et al. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35: 567-576.
20. LAHIRI, D.K., S. LEWIS, & M.R. FARLOW. 1994. Tacrine alters the processing of beta-amyloid precursor protein in different cell lines. J. Neurosci. Res. 37: 777-787.
21. LAHIRI, D.K. 1999. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types. J. Pineal Res. 26: 137-146.
22. SONG, W., & D.K. LAHIRI. 1997. Melatonin alters the metabolism of beta-amyloid precursor protein in the neuroendocrine cell line PC12. J. Mol. Neurosci. 9: 75-92.
23. JANZ, R., T.C. SUDHOF, R.E. HAMMER, et al. 1999. Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I. Neuron 24: 687-700.
24. GRAHAM, M.E., P. WASHBOURNE, M.C. WILSON, et al. 2002. Molecular analysis of SNAP-25 function in exocytosis. Ann. N. Y. Acad. Sci. 971: 210-221.
25. LAHIRI, D.K., D. CHEN, Y.W. GE, et al. 2004. Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J. Pineal Res. 36: 224-231.
26. BROWN, D.F., R.C. RISSER, E.H. BIGIO, et al. 1998. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J. Neuropathol. Exp. Neurol. 57: 955-960.
27. SZE, C.I., J.C. TRONCOSO, C. KAWAS, et al. 1997. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56: 933-944.